REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,733,320 | +12.1% | 17,000 | 0.0% | 0.10% | +7.9% |
| Q1 2023 | $1,545,640 | +139.3% | 17,000 | 0.0% | 0.09% | +117.1% |
| Q4 2022 | $645,830 | +51.2% | 17,000 | 0.0% | 0.04% | +46.4% |
| Q3 2022 | $427,000 | -17.4% | 17,000 | 0.0% | 0.03% | -12.5% |
| Q2 2022 | $517,000 | -7.2% | 17,000 | 0.0% | 0.03% | +23.1% |
| Q1 2022 | $557,000 | +24.3% | 17,000 | 0.0% | 0.03% | +36.8% |
| Q4 2021 | $448,000 | -73.8% | 17,000 | 0.0% | 0.02% | -77.4% |
| Q3 2021 | $1,710,000 | -28.9% | 17,000 | 0.0% | 0.08% | -30.6% |
| Q2 2021 | $2,406,000 | +41.9% | 17,000 | 0.0% | 0.12% | +28.7% |
| Q1 2021 | $1,695,000 | -19.4% | 17,000 | 0.0% | 0.09% | -23.6% |
| Q4 2020 | $2,102,000 | +26.9% | 17,000 | 0.0% | 0.12% | +9.8% |
| Q3 2020 | $1,656,000 | -37.6% | 17,000 | 0.0% | 0.11% | -42.0% |
| Q2 2020 | $2,652,000 | +8.1% | 17,000 | 0.0% | 0.19% | -1.0% |
| Q1 2020 | $2,454,000 | -29.4% | 17,000 | 0.0% | 0.20% | -15.6% |
| Q4 2019 | $3,475,000 | +14.2% | 17,000 | -55.1% | 0.23% | +8.5% |
| Q3 2019 | $3,043,000 | +11.2% | 37,900 | +30.7% | 0.21% | +16.4% |
| Q2 2019 | $2,736,000 | +4.6% | 29,000 | -5.2% | 0.18% | -4.2% |
| Q1 2019 | $2,615,000 | +42.1% | 30,600 | -6.7% | 0.19% | +24.8% |
| Q4 2018 | $1,840,000 | -31.4% | 32,800 | 0.0% | 0.15% | -18.2% |
| Q3 2018 | $2,682,000 | +86.5% | 32,800 | -20.2% | 0.19% | +70.0% |
| Q2 2018 | $1,438,000 | +338.4% | 41,118 | +157.0% | 0.11% | +307.4% |
| Q1 2018 | $328,000 | -27.6% | 16,000 | 0.0% | 0.03% | -27.0% |
| Q4 2017 | $453,000 | -9.0% | 16,000 | 0.0% | 0.04% | -17.8% |
| Q3 2017 | $498,000 | -20.3% | 16,000 | -19.0% | 0.04% | -21.1% |
| Q2 2017 | $625,000 | +39.8% | 19,753 | 0.0% | 0.06% | +32.6% |
| Q1 2017 | $447,000 | – | 19,753 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |